Haemostatic derangements after acute severe colitis and implications for duration of thromboprophylaxis.

Haemostatic derangements after acute severe colitis and implications for duration of thromboprophylaxis. - Haemostatic profile in ASC

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON40875

Enrollment

Registered

2014-09-24

Start date

2014-12-17

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

inflammatory bowel disease Ulcerative colitis

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: * Male or Female, aged 18 years or above;* Cases: o Adult patients with ASC (Montreal S3 as defined by passage of *6 bloody stools daily with one or more of the following: heart rate *90 bpm, temperature * 37.8°C (99.5°F), haemoglobin level of

Exclusion criteria

Exclusion criteria: * Age

Design outcomes

Primary

Measure	Time frame
To provide a comprehensive assessment of the haemostatic profile of patients with acute severe colitis (ASC) during hospitalization and up to 12 weeks post-discharge from hospital (page 12).	—

Secondary

Measure	Time frame
1. To identify biomarkers of a pro-thrombotic state in patients with ASC that could be used to identify patients at highest risk of VTE, to guide the duration of thromboprophylaxis and monitor response to treatment. 2. To inform the need for clinical studies of extended thromboprophylaxis for patients with ASC after discharge from hospital	—

Countries

Netherlands

Outcome results